1.41
-0.08(-5.37%)
Currency In USD
| Previous Close | 1.49 |
| Open | 1.49 |
| Day High | 1.5 |
| Day Low | 1.4 |
| 52-Week High | 3 |
| 52-Week Low | 1 |
| Volume | 82,299 |
| Average Volume | 115,193 |
| Market Cap | 9.74M |
| PE | -1.06 |
| EPS | -1.33 |
| Moving Average 50 Days | 1.37 |
| Moving Average 200 Days | 1.59 |
| Change | -0.08 |
If you invested $1000 in Intelligent Bio Solutions Inc. (INBS) since IPO date, it would be worth $0.53 as of May 31, 2025 at a share price of $1.41. Whereas If you bought $1000 worth of Intelligent Bio Solutions Inc. (INBS) shares 3 years ago, it would be worth $10.12 as of May 31, 2025 at a share price of $1.41.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing
GlobeNewswire Inc.
May 22, 2025 12:30 PM GMT
INBS to participate with U.S. distribution partner SMARTOX at RISE25, the leading U.S. conference on addiction, mental health, and justice innovation which draws over 7,000 attendees annually With over 450 active accounts across 24 countries, INBS co
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment
GlobeNewswire Inc.
May 19, 2025 12:30 PM GMT
Completion of 160 tests conducted in less than 90 minutes demonstrates a level of speed and efficiency beyond the limits of traditional testing approachesNEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INB
Intelligent Bio Solutions Accelerates Global Adoption of Fingerprint Drug Testing
GlobeNewswire Inc.
May 15, 2025 1:00 PM GMT
Company surpasses 450 accounts across 24 countries as global demand for fingerprint drug testing surgesNEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company